|
Health and Pharmaceutical News
Search our news archive and company websites…
New
Cancer Drugs Harness Power of Immune System 3:48 AM 5/16/2013
Wall Street Journal
Bristol-Myers' melanoma treatment Yervoy and experimental nivolumab resulted in tumor regressions in nearly one-third of skin cancer patients.
...
See
all stories on this topic
FDA
approves Glaxo/Theravance drug for COPD lung disease 8:58 AM 5/10/2013
Chicago Tribune
Breo contains the corticosteroid fluticasone and long-acting beta-agonist vilanterol designed to open the airways.
...
See
all stories on this topic
Eli
Lilly lymphoma drug fails in late-stage trial 7:37 AM 5/10/2013
Reuters
Eli Lilly will end development of experimental lymphoma drug enzastaurin.
...
See
all stories on this topic
Drug
fails to slow Alzheimer's 9:38 AM 5/7/2013
USA TODAY
Baxter International's Gammagard failed to slow mental decline or to preserve physical function.
...
See
all stories on this topic
Drug-resistant
strains of malaria parasite identified 6:54 AM 4/30/2013
Fox News
Artemisinin resistance could derail global malaria control advances in recent years.
...
See
all stories on this topic
Seizure
Drug Used in Pregnancy Boosts Baby's Autism Risk 1:53 AM 4/24/2013
Businessweek
Epilepsy drug valproate was also tied to a three-fold increase of autism spectrum disorder including Asperger syndrome.
...
See
all stories on this topic
FDA Approves Morning Sickness Drug Once Feared Unsafe 7:51 AM 4/9/2013
ABC News
Duchesnay USA's Diclegis (doxylamine and pyridoxine) becomes the only FDA-approved drug to treat the pregnancy-related symptoms of nausea and vomiting.
...
See all stories on this topic
FDA
approves Biogen's oral MS drug, Tecfidera 3:21 PM 3/27/2013
Reuters
Tecfidera activates the body's Nrf2 pathway protecting nerve cells from
damage and inflammation.
...
See
all stories on this topic
Melanoma
Drug Succeeds in Late-Stage Trial 4:21 AM 3/20/2013
New York Times
Patients treated with Amgen's talimogene laherparepvec (TVEC) experienced a significant shrinkage of tumors for six months.
...
See
all stories on this topic
FDA
reviewers say Titan drug dose may be insufficient 2:36 PM 3/19/2013
Reuters
Titan's Probuphine long-acting version of buprenorphine is implanted under the skin of the upper arm.
...
See
all stories on this topic
Novartis
cleared by EU for eye-care drug Jetrea 1:12 AM 3/18/2013
MarketWatch
Jetrea treats vitreomacular traction (VMT) which can cause holes in the eye's macula.
...
See
all stories on this topic
FDA
Plans Looser Rules on Approving Alzheimer's Drugs 4:55 AM 3/14/2013
New York Times
There might be approval at very early stages of the disease where improved performance on memory or reasoning tests can be proven.
...
See
all stories on this topic
FDA
approves imaging drug for cancer lymph nodes 1:55 PM 3/13/2013
USA TODAY
Navidea Biopharmaceuticals' radioactive imaging agent Lymphoseek is intended to find breast cancer or melanoma that has spread to lymph nodes.
...
See
all stories on this topic
Experimental
Roche drug shows promise in reducing heart damage 6:33 PM 3/10/2013
Reuters
Inclacumab blocks the p-selectin antibody associated with inflammation that can destabilize plaque in the arteries and lead to heart attack.
...
See
all stories on this topic
Web
searches could expose new drug side effects 6:00 AM 3/8/2013
CNN International
US FDA drug approvals don't include exhaustive studies of every potential combination of drugs.
...
See
all stories on this topic
GlaxoSmithKline
files for European approval of diabetes drug
albiglutide 2:56 AM 3/7/2013
Reuters
Albiglutide is a latecomer to the crowded GLP-1 market with regulatory approval pending in the US.
...
See
all stories on this topic
Celgene
drug shown to be effective, safe in psoriasis trial 7:21 AM 3/2/2013
Reuters
Apremilast inhibits the phosphodiesterase 4 enzyme (PDE4) reducing inflammation.
...
See
all stories on this topic
FDA
Wants to Regulate Drug Firms on the Internet 1:59 AM 2/27/2013
Forbes
The US FDA’s interpretation that a “Like” implies endorsement could be precedent setting.
...
See
all stories on this topic
FDA
OKs drug for painful sex caused by menopause 2:29 PM 2/26/2013
CBS News
Shionogi's Osphena treats menopausal symptoms that make vaginal tissue thinner and fragile.
...
See
all stories on this topic
FDA
halts trials of Amgen drug in children, cites death 1:12 PM 2/26/2013
Reuters
A 14-year-old patient dies while taking part in a study of Amgen's Sensipar.
...
See
all stories on this topic
FDA rejects Dynavax adult hepatitis B vaccine 5:30 AM 2/25/2013
Reuters
The US FDA wants additional data to evaluate Dynavax Technologies' faster-acting and less frequently needed vaccine.
...
See
all stories on this topic
Takeda,
Affymax Recall Omontys Drug After 'Serious'
Reactions 4:47 AM 2/24/2013
Bloomberg
The anemia treatment for kidney dialysis patients may cause “serious hypersensitivity reactions” that could be fatal.
...
See
all stories on this topic
FDA
approves Roche drug for late-stage breast cancer 3:16 PM 2/22/2013
Reuters
The US FDA approves Kadcyla (ado-trastuzumab emtansine) for patients whose cancer cells contain increased amounts of HER2 protein.
...
See
all stories on this topic
Fatal
drug overdoses in US increase for 11th consecutive
year 1:00 PM 2/19/2013
Los Angeles Times
Over three quarters of overdoses involved central nervous system depressant like Valium, Xanax, or Ativan.
...
See
all stories on this topic
US
FDA okays Novartis drug to prevent liver transplant
rejection 4:19 PM 2/15/2013
Reuters
Novartis' Zortress approved for preventing organ rejection in adult patients receiving a liver transplant.
...
See
all stories on this topic
Novo
Nordisk sinks on disappointing drug news 8:30 AM 2/11/2013
MarketWatch
The US FDA rejects new drug applications for long acting insulin Tresiba and related Ryzodeg.
...
See
all stories on this topic
Modified
Smallpox Vaccine Stymies Liver Cancer in Study 10:33 AM 2/10/2013
Bloomberg
Jennerex Inc's Pexa-Vec (JX-594) reduced size of tumors in liver cancer patients and extended survival more than a year.
...
See
all stories on this topic
FDA
approves Celgene drug for multiple myeloma 1:31 PM 2/8/2013
Reuters
The US FDA approves Pomalyst (pomalidomide) for the most difficult-to-treat multiple myeloma patients.
...
See
all stories on this topic
Lilly
stops development of rheumatoid arthritis drug 1:33 PM 2/7/2013
Reuters
Tabalumab will be tested as a treatment for the autoimmune disorder systemic lupus erythematosus and multiple myeloma.
...
See
all stories on this topic
Biogen's
purchase of MS drug ends rocky partnership with Elan 1:07 AM 2/7/2013
Reuters
Biogen gains full control of multiple sclerosis drug Tysabri which is poised for further growth.
...
See
all stories on this topic
Gilead's
two hepatitis C drug trials meet study goals 2:09 PM 2/4/2013
Reuters
Nucleotide sofosbuvir was tested for 12 weeks in previously untreated patients who have chronic hepatitis C virus (HCV) infection.
...
See
all stories on this topic
Sanofi's
diabetes drug Lyxumia approved in Europe 7:33 AM 2/4/2013
Reuters
Lyxumia (lixisenatide) is an injectable diabetes treatment marketed in Europe.
...
See
all stories on this topic
Merck
Delays Osteoporosis Drug 12:53 PM 2/1/2013
New York Times
Merck is delaying its market application for new drug odanacatib.
...
See
all stories on this topic
FDA
approves new drug for the chronic management of urea cycle
disorders 9:53 AM 2/1/2013
FDA.gov
The US FDA approved Ravicti (glycerol phenylbutyrate) for the chronic management of certain urea cycle disorders (UCDs) in patients over the age of two.
...
See
all stories on this topic
European
Officials Say Drug Makers Paid to Delay Generic
Version 3:13 AM 2/1/2013
New York Times
Johnson & Johnson and Novartis accused of colluding to delay availability of less expensive generic cancer pain drug.
...
See
all stories on this topic
Roche
Blood Cancer Drug Meets Key Goal In Trial 12:47 PM 1/31/2013
Wall Street Journal
The experimental medicine could become
a successor to the company's best-selling drug.
...
See
all stories on this topic
FDA
Approves Genetic Drug to Treat Rare Disease 1:15 AM 1/30/2013
New York Times
Isis/Genzyme's Kynamro could become the first commercial success for antisense gene silencing technique.
...
See
all stories on this topic
Biogen's
Longer-Lasting MS Drug Meets Goals in Late Trial 10:57 AM 1/24/2013
Bloomberg
Injectable multiple sclerosis drug peginterferon beta-1a reduced risk of relapse by 36 percent when given every two weeks. ...
See
all stories on this topic
Pancreatic
Cancer Drug Found to Extend Life 1:02 AM 1/23/2013
New York Times
Celgene's Abraxane prolonged
lives of patients with advanced pancreatic cancer by almost two
months not seen as a breakthrough.
...
See
all stories on this topic
Lilly
Drug Extends Survival in Gastric-Cancer Study 7:02 PM 1/22/2013
Fox Business
Survival advantage of less two months for ramucirumab could prompt regulators to wait for further testing.
...
See
all stories on this topic
Rapidly Produced Flu Vaccine Wins FDA Approval 2:19 AM 1/17/2013
New York Times
Protein Sciences' process does not require a virus grown in chicken eggs allowing vaccines ready weeks earlier.
...
See all stories on this topic
Pfizer moves may signal drug-unit breakup
3:35 AM 1/16/2013
San Francisco Chronicle
The world's largest drugmaker may be preparing to split in two.
...
See all stories on this topic
GSK
files for US approval of new diabetes drug 3:43 AM 1/14/2013
Reuters
GlaxoSmithKline files for US approval of once-weekly diabetes drug albiglutide to compete with Victoza and Byetta and Bydureon.
...
See
all stories on this topic
Glaxo
Future Hangs in Balance on 2013 Drug Approvals 1:46 AM 1/11/2013
Businessweek
Five new drugs submitted to regulators may signal that help is on the way.
...
See
all stories on this topic
<- Earlier Stories
See All
  
|
